The Scientist1y
Immunogenicity Testing: Challenges and Strategies
Hence, early testing and prediction of potential immunogenicity and allergenicity caused by these drugs is essential, but can be quite challenging. Hosted by The Scientist, this live webinar brings ...
FDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugates
A new article in the journal Nucleic Acid Therapeutics addresses the recognition by the U.S. Food and Drug Administration ...
Oral norovirus vaccine passes safety testing with a strong immune response in older adults
Researchers at Vaxart Inc. and the Center for Vaccine Development at the University of Maryland School of Medicine evaluated ...
The Scientist1mon
Considerations for Cell-Based Assays in Immuno-Oncology Research
In the immuno-oncology field, scientists discover, test, and validate novel immunotherapeutic agents ... researchers must evaluate a treatment’s immunogenicity, which includes a broad spectrum of ...
Morningstar8d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13th International RSV Symposium
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV ... candidate that is currently in Phase 1/2a clinical testing in children ages eight to 59 months of age.
Business Wire9d
Blue Lake Biotechnology to Present Safety and Immunogenicity Data for its RSV Intranasal Vaccine Candidate at the 13 th International RSV Symposium
Presentation Details Title: Safety and Immunogenicity of PIV5-Vectored ... candidate that is currently in Phase 1/2a clinical testing in children ages eight to 59 months of age.